GEHC monthly performance report
Check GEHC's monthly returns, drawdown, and seasonality trends — updated every month.
GEHC monthly report
—
Key takeaways
- GE HealthCare (GEHC) closed November 2026 at $81.84, up 6.88% for the month and +9.15% over the trailing 12 months.
- Year-to-date, GEHC is −0.22%, underperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +16.85% versus its 200-day moving average ($70.04), a bullish technical signal.
- Over the past three years, GEHC has underperformed the S&P 500 by −54.11%, with a relative strength index reading of 68.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
GE HealthCare ended November 2026 at $81.84, posting a monthly return of +6.88%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +6.70%.
The current quarter stands at +25.20% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +16.85% versus the 200-day moving average ($70.04).
Year-to-date, GEHC is −0.22% against SPY +11.03%, a gap of −11.25%. The stock is currently −8.83% below its 52-week high, with maximum 3-year drawdown at −37.41%.
| Period | GEHC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.92% | −0.35% | −0.57% |
| 1 Week | −2.28% | +3.29% | −5.57% |
| 1 Month | +6.88% | +0.19% | +6.70% |
| 3 Months | +10.91% | −2.48% | +13.39% |
| 6 Months | +31.39% | +2.00% | +29.39% |
| YTD | −0.22% | +11.03% | −11.25% |
| 12 Months | +9.15% | +10.79% | −1.64% |
| 3 Years | +17.72% | +71.83% | −54.11% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2024 | +24.43% |
| #2 | Oct 2026 | +17.13% |
| #3 | Jan 2025 | +12.94% |
| #4 | Dec 2023 | +12.94% |
| #5 | Sep 2024 | +10.65% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2024 | −16.14% |
| #2 | Mar 2026 | −15.53% |
| #3 | Apr 2026 | −14.53% |
| #4 | Apr 2025 | −12.86% |
| #5 | Sep 2026 | −8.23% |
| Quarter | Return |
|---|---|
| Q3 2025 | +1.39% |
| Q4 2025 | +9.21% |
| Q1 2026 | −13.22% |
| Q2 2026 | −10.07% |
| Q3 2026 | +2.12% |
| Q4 2026 (QTD) | +25.20% |
| Year | Return |
|---|---|
| 2023 | +32.44% |
| 2024 | +1.11% |
| 2025 | +4.91% |
| 2026 | −0.22% |
| Metric | Value |
|---|---|
| 52-Week High | $89.77 (2026-01-08) |
| 52-Week Low | $58.75 (2026-04-29) |
| Current Price | $81.84 |
| 200-Day Moving Average | $70.04 |
| Price vs 200DMA | +16.85% |
| 3-Year Maximum Drawdown | −37.41% (2025-04-08) |
| Current Drawdown from 52W High | −8.83% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 68 |
| 3-Year Excess Return vs S&P 500 | −54.11% |
| RS Peak | 115.5 (Feb 2024) |
| RS Trough | 51.2 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was GEHC's return for this report period?
GEHC returned +6.88% in the latest monthly window ending 2026-11-12.
Has GEHC outperformed SPY year to date?
YTD GEHC: −0.22% vs SPY: +11.03%.
What is GEHC's 12-month return?
+9.15% over the trailing 12 months.
Is GEHC above or below its 200-day moving average?
Price is +16.85% versus 200DMA ($70.04).
What is the maximum drawdown in the 3-year window?
−37.41% on 2025-04-08.